![Brian Drazba](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brian Drazba
Plus aucun poste en cours
Fortune : 5 363 $ au 31/05/2024
Historique de carrière de Brian Drazba
Anciens postes connus de Brian Drazba
Sociétés | Poste | Début | Fin |
---|---|---|---|
MEI PHARMA, INC. | Comptroller/Controller/Auditor | 03/04/2017 | - |
Directeur Financier/CFO | 03/04/2017 | 01/08/2023 | |
Secrétaire Général | 03/04/2017 | 01/08/2023 | |
HERON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 04/10/2013 | 31/03/2017 |
Directeur Financier/CFO | 04/10/2013 | 31/03/2017 | |
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Comptroller/Controller/Auditor | 01/06/2009 | 01/06/2012 |
InSight Health Corp.
![]() InSight Health Corp. Medical/Nursing ServicesHealth Services InSight Health Corp. provides diagnostic imaging and therapeutic healthcare services. It provides services to patients, physicians, managed care entities, hospitals and other contractual customers. The company was founded in 1996 and is headquartered in St. Louis Park, MN. | Comptroller/Controller/Auditor | 01/01/1992 | 01/01/2009 |
InSight Health Services Holdings Corp.
![]() InSight Health Services Holdings Corp. Medical/Nursing ServicesHealth Services Insight Health Services Holdings Corp. provides fixed site and mobile diagnostic imaging services. It offers magnetic resonance imaging, computed and positron emission tomography, as well as other radiological services. The company was founded in 2001 and is headquartered in St. Louis Park, MN. | Comptroller/Controller/Auditor | - | - |
Formation de Brian Drazba
University of San Diego | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Comptroller/Controller/Auditor | 5 |
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Health Services | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
HERON THERAPEUTICS, INC. | Health Technology |
MEI PHARMA, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
InSight Health Corp.
![]() InSight Health Corp. Medical/Nursing ServicesHealth Services InSight Health Corp. provides diagnostic imaging and therapeutic healthcare services. It provides services to patients, physicians, managed care entities, hospitals and other contractual customers. The company was founded in 1996 and is headquartered in St. Louis Park, MN. | Health Services |
InSight Health Services Holdings Corp.
![]() InSight Health Services Holdings Corp. Medical/Nursing ServicesHealth Services Insight Health Services Holdings Corp. provides fixed site and mobile diagnostic imaging services. It offers magnetic resonance imaging, computed and positron emission tomography, as well as other radiological services. The company was founded in 2001 and is headquartered in St. Louis Park, MN. | Health Services |
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
- Bourse
- Insiders
- Brian Drazba
- Expérience